
### [MONDO:0017738](http://purl.obolibrary.org/obo/MONDO_0017738)
**Label:** lysosomal glycogen storage disease

**Subclasses:** [MONDO:0010281](http://purl.obolibrary.org/obo/MONDO_0010281) (Danon disease), [MONDO:0017694](http://purl.obolibrary.org/obo/MONDO_0017694) (glycogen storage disease due to acid maltase deficiency, infantile onset), [MONDO:0018485](http://purl.obolibrary.org/obo/MONDO_0018485) (glycogen storage disease due to acid maltase deficiency, late-onset), [MONDO:0009290](http://purl.obolibrary.org/obo/MONDO_0009290) (glycogen storage disease II), 

**Corr. equiv. classes:** [OMIM:232300](http://purl.obolibrary.org/obo/OMIM_232300), [Orphanet:420429](http://www.orpha.net/ORDO/Orphanet_420429), [Orphanet:365](http://www.orpha.net/ORDO/Orphanet_365), [OMIM:300257](http://purl.obolibrary.org/obo/OMIM_300257), [Orphanet:34587](http://www.orpha.net/ORDO/Orphanet_34587), [Orphanet:308552](http://www.orpha.net/ORDO/Orphanet_308552), 

**Class expressions from DL-Learner:**

- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) 66.67%
- [HP:0001640](http://purl.obolibrary.org/obo/HP_0001640) (Cardiomegaly) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0001640](http://purl.obolibrary.org/obo/HP_0001640) (Cardiomegaly) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 66.67%
- [HP:0001640](http://purl.obolibrary.org/obo/HP_0001640) (Cardiomegaly) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 66.67%
- [HP:0001640](http://purl.obolibrary.org/obo/HP_0001640) (Cardiomegaly) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0001716](http://purl.obolibrary.org/obo/HP_0001716) (Wolff-Parkinson-White syndrome) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%


